Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Stockholders Equity of $7.07 million for fiscal year 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.07M | +760.4% |
| 2024 | $822.0K | -86.8% |
| 2023 | $6.25M | -34.9% |
| 2022 | $9.60M | +46.5% |
| 2021 | $6.55M | +217.2% |
| 2020 | $2.07M | +267.0% |
| 2019 | -$1.24M | +71.8% |
| 2018 | -$4.40M | +12.7% |
| 2017 | -$5.04M | -1791.9% |
| 2016 | -$266.2K | -226.7% |
| 2015 | -$81.5K | -130.3% |
| 2014 | -$35.4K | -16.8% |
| 2013 | -$30.3K | -75.7% |
| 2012 | -$17.2K | -426.0% |
| 2011 | -$3.3K | +24.2% |
| 2010 | -$4.3K | -454.1% |
| 2009 | $1.2K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $6.40M | +118.1% | -9.5% |
| September 30, 2025 | $7.07M | +760.4% | -13.5% |
| June 30, 2025 | $8.18M | +171.5% | +626.3% |
| March 31, 2025 | $1.13M | -70.8% | -61.6% |
| December 31, 2024 | $2.94M | -33.6% | +257.1% |
| September 30, 2024 | $822.0K | -86.8% | -72.7% |
| June 30, 2024 | $3.01M | -23.2% | -21.9% |
| March 31, 2024 | $3.85M | -30.3% | -12.8% |
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +760.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, NEUROONE MEDICAL TECHNOLOGIES Corp’s stockholders equity has grown by 579140.1% (from $1.2 thousand to $7.07 million).
- The most recent figure is from NEUROONE MEDICAL TECHNOLOGIES Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: